We are live on ! Find out more
IDXX icon

Idexx Laboratories

613 hedge funds and large institutions have $11.9B invested in Idexx Laboratories in 2017 Q4 according to their latest regulatory filings, with 79 funds opening new positions, 162 increasing their positions, 265 reducing their positions, and 36 closing their positions.

New
Increased
Maintained
Reduced
Closed

119% more first-time investments, than exits

New positions opened: 79 | Existing positions closed: 36

7% more funds holding

Funds holding: 573613 (+40)

0% more funds holding in top 10

Funds holding in top 10: 1515 (0)

7% less capital invested

Capital invested by funds: $12.8B → $11.9B (-$902M)

16.3% less ownership

Funds ownership: 103.58%87.28% (-16%)

39% less repeat investments, than reductions

Existing positions increased: 162 | Existing positions reduced: 265

49% less call options, than puts

Call options by funds: $16.5M | Put options by funds: $32.3M

Holders
613
Holders Change
+40
Holders Change %
+6.98%
% of All Funds
13.9%
Holding in Top 10
15
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.34%
New
79
Increased
162
Reduced
265
Closed
36
Calls
$16.5M
Puts
$32.3M
Net Calls
-$15.8M
Net Calls Change
-$13.3M
Name Holding Trade Value Shares
Change
Change in
Stake
QC
251
Quadrature Capital
United Kingdom
$1.96M +$1.97M +12,525 New
CGH
252
Crossmark Global Holdings
Texas
$1.96M -$665K -4,223 -25%
US Bancorp
253
US Bancorp
Minnesota
$1.96M -$171K -1,088 -8%
Citigroup
254
Citigroup
New York
$1.92M -$3.03M -19,252 -61%
SW
255
SVB Wealth
Massachusetts
$1.91M +$2.99K +19 +0.2%
AAMU
256
AEGON Asset Management (UK)
United Kingdom
$1.91M
MSA
257
Mason Street Advisors
Wisconsin
$1.9M +$5.19K +33 +0.3%
AAF
258
Andra AP-fonden
Sweden
$1.89M -$929K -5,900 -33%
Nomura Asset Management
259
Nomura Asset Management
Japan
$1.89M +$13.5K +86 +0.7%
GF
260
Gabelli Funds
New York
$1.86M -$15.7K -100 -0.8%
Connor, Clark & Lunn Investment Management (CC&L)
261
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$1.85M +$881K +5,600 +90%
Bessemer Group
262
Bessemer Group
New Jersey
$1.8M -$10.9K -69 -0.6%
AB
263
Amalgamated Bank
New York
$1.8M +$158K +1,006 +10%
EGM
264
Engineers Gate Manager
New York
$1.8M -$521K -3,307 -22%
TRSOTSOK
265
Teachers Retirement System of the State of Kentucky
Kentucky
$1.8M -$63K -400 -3%
Victory Capital Management
266
Victory Capital Management
Texas
$1.8M +$167K +1,060 +10%
CIBC Asset Management
267
CIBC Asset Management
Ontario, Canada
$1.79M +$80.3K +510 +5%
MSV
268
MN Services Vermogensbeheer
Netherlands
$1.78M -$94.4K -600 -4%
LRIC
269
Long Road Investment Counsel
Michigan
$1.76M
Marshall Wace
270
Marshall Wace
United Kingdom
$1.74M +$23.8K +151 +1%
OWP
271
Obermeyer Wealth Partners
Colorado
$1.74M -$47.2K -300 -3%
MOACM
272
Mutual of America Capital Management
New York
$1.71M +$163K +1,037 +10%
NB
273
Norinchukin Bank
Japan
$1.68M +$673K +4,276 +66%
M&T Bank
274
M&T Bank
New York
$1.68M -$5.19K -33 -0.3%
B
275
BP
United Kingdom
$1.64M

IDXX Hedge Fund Activity: Q4 2017 in Review

613 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Idexx Laboratories (IDXX) for Q4 2017, worth a combined $11.9B — down 7.1% from $12.8B a quarter earlier.

Buyers outnumbered sellers: 79 funds opened new IDXX positions and 36 closed out — a net gain of 43 holders — while 162 added to existing stakes and 265 trimmed.

The largest buyer was William Blair Investment Management, adding an estimated $78.8M. The largest seller was Fundsmith LLP, cutting an estimated $2.22B.

  • 613 institutional investors held Idexx Laboratories (IDXX) as of Q4 2017, up from 573 in Q3 2017.
  • Funds reported $11.9B of Idexx Laboratories stock for Q4 2017, down 7.1% quarter-over-quarter.
  • 79 funds opened new Idexx Laboratories positions in Q4 2017 and 36 closed out, a net change of +43 holders.
  • The largest Idexx Laboratories buyer in Q4 2017 was William Blair Investment Management, an estimated $78.8M added.
  • The largest Idexx Laboratories seller in Q4 2017 was Fundsmith LLP, an estimated $2.22B sold.

Based on aggregated 13F filings for Q4 2017.